Selva Therapeutics

Selva Therapeutics

Pharmaceutical Manufacturing San Diego, Ca, United States 4 employees
Employees
4
Contacts
2
Emails
2
Phones
1

Selva Therapeutics Overview

Headquarters
San Diego, Ca, United States
Website
selvarx.com
Industry
Pharmaceutical Manufacturing
Employees
4
Funding
3.0M
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Selva Therapeutics

Selva Therapeutics is a privately held biotechnology company dedicated to the development of therapeutics for infectious diseases. The company’s lead drug candidate, SLV213, is an orally available small molecule novel antiviral therapy with activity against a broad range of viruses that threaten global health, including SARS-CoV-2, the virus causing COVID-19. In addition, SLV213 has activity against Ebola and Nipah viruses and has completed preclinical development as a potential therapy against Chagas disease. Selva is headquartered in San Diego.

Selva Therapeutics Contact Details

People in AeroLeads
2
With contact data
2
Email contacts
2
100.0% coverage
Phone contacts
1
50.0% coverage

Selva Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Laura Hix Glickman Biotechnology Entrepreneur & Advisor
Email Phone
Ted Daley
Email

Compare Similar Companies to Selva Therapeutics